Episode 134: Obesity, GLP 1s, and the Missing Link in AFib Care
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
In this Controversies in EP episode, #HRStv host Nashwa Abdulsalam, MBBS, is joined by Nicolette Bembenek, MD, to discuss a key gap in managing AFib. While electrophysiologists are comfortable prescribing antiarrhythmic drugs and performing ablations, there's often no clear plan when it comes to addressing weight management. In this discussion, they explore the complex risk factors behind obesity, how it impacts AFib care, and where emerging therapies like GLP-1 receptor agonists may fit into the conversation.
Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.